Comments on: "Perioperative bridging anticoagulation in patients with atrial fibrillation"
References
1. Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373: 823-33.
2. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:7S-47S.
3. Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation. 2012;126:1630-9.
4. Philip I, Berroeta C, Leblanc I. Perioperative challenges of atrial fibrillation. Curr Opin Anaesthesiol. 2014;27: 344-52.
5. Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med. 2004;164: 1319-26.
6. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med. 2003;163:901-8.
7. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Group C. Reporting of noninferiority and equivalence randomized trials: an extension of the consort statement. JAMA. 2006;295:1152-60.
8. Hahn S. Understanding noninferiority trials. Korean J Pediatr. 2012;55:403-7.
9. Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the rely trial. Thromb Haemost. 2015;113: 625-32.
10. Liesegang TJ. Evidence-based medicine: principles for applying the users' guides to patient care. Guyatt GH,* Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, Wilson MC, Richardson WS for the Evidence-Based Medicine Working Group. JAMA 2000;284:1290-1296. Am J Ophthalmol. 2001;131:153.
11. Douketis JD. Anticoagulation therapy: perioperative anticoagulation-are we at 'a bridge too far'? Nat Rev: Cardiol. 2015;12:133-4.
2. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:7S-47S.
3. Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation. 2012;126:1630-9.
4. Philip I, Berroeta C, Leblanc I. Perioperative challenges of atrial fibrillation. Curr Opin Anaesthesiol. 2014;27: 344-52.
5. Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med. 2004;164: 1319-26.
6. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med. 2003;163:901-8.
7. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Group C. Reporting of noninferiority and equivalence randomized trials: an extension of the consort statement. JAMA. 2006;295:1152-60.
8. Hahn S. Understanding noninferiority trials. Korean J Pediatr. 2012;55:403-7.
9. Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the rely trial. Thromb Haemost. 2015;113: 625-32.
10. Liesegang TJ. Evidence-based medicine: principles for applying the users' guides to patient care. Guyatt GH,* Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, Wilson MC, Richardson WS for the Evidence-Based Medicine Working Group. JAMA 2000;284:1290-1296. Am J Ophthalmol. 2001;131:153.
11. Douketis JD. Anticoagulation therapy: perioperative anticoagulation-are we at 'a bridge too far'? Nat Rev: Cardiol. 2015;12:133-4.
How to Cite
1.
Oliveros-Rodríguez H, Ruiz-Ávila HA. Comments on: "Perioperative bridging anticoagulation in patients with atrial fibrillation". Colomb. J. Anesthesiol. [Internet]. 2015 Oct. 1 [cited 2024 Apr. 23];43(4):340–342. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/358
Downloads
Download data is not yet available.
Published
2015-10-01
How to Cite
1.
Oliveros-Rodríguez H, Ruiz-Ávila HA. Comments on: "Perioperative bridging anticoagulation in patients with atrial fibrillation". Colomb. J. Anesthesiol. [Internet]. 2015 Oct. 1 [cited 2024 Apr. 23];43(4):340–342. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/358
Issue
Section
Brief academy
Altmetric
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
